Galenica

Galenica company information, Employees & Contact Information

Explore related pages

Related company profiles:

Galenica (the “Company”) is a leading IVD player in Chile focus on Clinical Laboratory, Molecular Biology, Quality Control, Blood Banking, Biotechnology, Medicine and Laboratory Information System (LIS) segments. Galénica imports, distributes and commercialize IVD reagents, consumables, instruments, and equipment along with an excellent after-sales service. Galenica focus on providing high quality and high technology products and solutions. The Company's offerings include consulting, training and a dedicated after-sales service that translates into added value for its customers. Galenica’s main customers include public and private hospitals, blood banks, clinical laboratories, universities, medical and research centers. Galenica has been in operation for more than 37 years in Chile and has recently expanded into Peru.

Company Details

Employees
121
Founded
-
Address
Av. Apoquindo 6314, Of. 205, Las Condes,chile
Phone
+56 2 2799 2900
Email
in****@****nica.cl
Industry
Medical And Diagnostic Laboratories
NAICS
Medical and Diagnostic Laboratories
Medical Laboratories
Diagnostic Imaging Centers
HQ
Santiago, RM
Looking for a particular Galenica employee's phone or email?

Galenica Questions

News

Galenica AG Reports Robust Q3 Growth and Raises Guidance - TipRanks

Galenica AG Reports Robust Q3 Growth and Raises Guidance TipRanks

Baker McKenzie Advises UBS on the Financing of Galenica’s Acquisition of the Labor Team Group - Baker McKenzie

Baker McKenzie Advises UBS on the Financing of Galenica’s Acquisition of the Labor Team Group Baker McKenzie

While institutions own 45% of Galenica AG (VTX:GALE), retail investors are its largest shareholders with 55% ownership - simplywall.st

While institutions own 45% of Galenica AG (VTX:GALE), retail investors are its largest shareholders with 55% ownership simplywall.st

Switzerland: Galenica enters diagnostics market with acquisition of Labor Team Group - Investors in Healthcare

Switzerland: Galenica enters diagnostics market with acquisition of Labor Team Group Investors in Healthcare

Galenica AG News Today: Stock Surges Amid Acquisition Speculation - Meyka

Galenica AG News Today: Stock Surges Amid Acquisition Speculation Meyka

Galenica AG Unveils Innovative Pharmacy Concept to Enhance Healthcare Services - TipRanks

Galenica AG Unveils Innovative Pharmacy Concept to Enhance Healthcare Services TipRanks

Planzer and Galenica launch Health Supply AG - Switzerland Global Enterprise

Planzer and Galenica launch Health Supply AG Switzerland Global Enterprise

Here's Why Galenica AG's (VTX:GALE) CEO May Have Their Pay Bumped Up - simplywall.st

Here's Why Galenica AG's (VTX:GALE) CEO May Have Their Pay Bumped Up simplywall.st

Pharmaceuticals: Galenica sets itself higher profit target after half-year | blue News - bluewin E-Mail

Pharmaceuticals: Galenica sets itself higher profit target after half-year | blue News bluewin E-Mail

3 Q&A interview with Kristina Thored, Vice President CDMO, MVA member Galenica - mva.org

3 Q&A interview with Kristina Thored, Vice President CDMO, MVA member Galenica mva.org

Despite Its High P/E Ratio, Is Galenica AG (VTX:GALE) Still Undervalued? - Yahoo Finance

Despite Its High P/E Ratio, Is Galenica AG (VTX:GALE) Still Undervalued? Yahoo Finance

Galenica Group focuses on pharmaceuticals as it becomes Vifor Pharma Group - News-Medical

Galenica Group focuses on pharmaceuticals as it becomes Vifor Pharma Group News-Medical

Galenica Sante raises $1.9 billion in Europe's biggest IPO this year - Reuters

Galenica Sante raises $1.9 billion in Europe's biggest IPO this year Reuters

All change at Galenica with split, IPO and name change - The Pharma Letter

All change at Galenica with split, IPO and name change The Pharma Letter

Galenica Group to Acquire Relypsa for $1.53B - Genetic Engineering and Biotechnology News

Galenica Group to Acquire Relypsa for $1.53B Genetic Engineering and Biotechnology News

Galenica snaps up Relypsa and its Veltassa med for $1.53B in march toward Vifor spinoff - Fierce Pharma

Galenica snaps up Relypsa and its Veltassa med for $1.53B in march toward Vifor spinoff Fierce Pharma

Galenica and Relypsa Announce Agreement for Galenica to Acquire Relypsa - GlobeNewswire

Galenica and Relypsa Announce Agreement for Galenica to Acquire Relypsa GlobeNewswire

Relypsa finally finds a buyer as Veltassa partner Galenica coughs up $1.5B - Fierce Biotech

Relypsa finally finds a buyer as Veltassa partner Galenica coughs up $1.5B Fierce Biotech

Relypsa Inc: RLYP Stock Pops 60% on Galenica Buyout Bid - Nasdaq

Relypsa Inc: RLYP Stock Pops 60% on Galenica Buyout Bid Nasdaq

The Returns At Galenica (VTX:GALE) Aren't Growing - simplywall.st

The Returns At Galenica (VTX:GALE) Aren't Growing simplywall.st

Galenica confident of meeting annual targets after strong half-year - SWI swissinfo.ch

Galenica confident of meeting annual targets after strong half-year SWI swissinfo.ch

Galenica Group strengthens management team - PMLiVE

Galenica Group strengthens management team PMLiVE

Apotheken-Netzwerk Galenica fühlt mit Zeam GenZ-Puls - markt-kom.com

Apotheken-Netzwerk Galenica fühlt mit Zeam GenZ-Puls markt-kom.com

EU clears Fresenius, Galenica pharma joint venture - Reuters

EU clears Fresenius, Galenica pharma joint venture Reuters

Top Galenica Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant